Role of AMP deaminase in diabetic cardiomyopathy
- PMID: 38386218
- DOI: 10.1007/s11010-024-04951-z
Role of AMP deaminase in diabetic cardiomyopathy
Abstract
Diabetes mellitus is one of the major causes of ischemic and nonischemic heart failure. While hypertension and coronary artery disease are frequent comorbidities in patients with diabetes, cardiac contractile dysfunction and remodeling occur in diabetic patients even without comorbidities, which is referred to as diabetic cardiomyopathy. Investigations in recent decades have demonstrated that the production of reactive oxygen species (ROS), impaired handling of intracellular Ca2+, and alterations in energy metabolism are involved in the development of diabetic cardiomyopathy. AMP deaminase (AMPD) directly regulates adenine nucleotide metabolism and energy transfer by adenylate kinase and indirectly modulates xanthine oxidoreductase-mediated pathways and AMP-activated protein kinase-mediated signaling. Upregulation of AMPD in diabetic hearts was first reported more than 30 years ago, and subsequent studies showed similar upregulation in the liver and skeletal muscle. Evidence for the roles of AMPD in diabetes-induced fatty liver, sarcopenia, and heart failure has been accumulating. A series of our recent studies showed that AMPD localizes in the mitochondria-associated endoplasmic reticulum membrane as well as the sarcoplasmic reticulum and cytosol and participates in the regulation of mitochondrial Ca2+ and suggested that upregulated AMPD contributes to contractile dysfunction in diabetic cardiomyopathy via increased generation of ROS, adenine nucleotide depletion, and impaired mitochondrial respiration. The detrimental effects of AMPD were manifested at times of increased cardiac workload by pressure loading. In this review, we briefly summarize the expression and functions of AMPD in the heart and discuss the roles of AMPD in diabetic cardiomyopathy, mainly focusing on contractile dysfunction caused by this disorder.
Keywords: Adenine nucleotides; Diabetic cardiomyopathy; Energy metabolism; Mitochondria-associated membrane; Reactive oxygen species; Xanthine oxidoreductase.
© 2024. The Author(s), under exclusive licence to Springer Science+Business Media, LLC, part of Springer Nature.
Similar articles
-
Xanthine oxidoreductase-mediated injury is amplified by upregulated AMP deaminase in type 2 diabetic rat hearts under the condition of pressure overload.J Mol Cell Cardiol. 2021 May;154:21-31. doi: 10.1016/j.yjmcc.2021.01.002. Epub 2021 Feb 4. J Mol Cell Cardiol. 2021. PMID: 33548240
-
Hyperglycemia-Driven Inhibition of AMP-Activated Protein Kinase α2 Induces Diabetic Cardiomyopathy by Promoting Mitochondria-Associated Endoplasmic Reticulum Membranes In Vivo.Circulation. 2019 Apr 16;139(16):1913-1936. doi: 10.1161/CIRCULATIONAHA.118.033552. Circulation. 2019. PMID: 30646747 Free PMC article.
-
An overview of the crosstalk between inflammatory processes and metabolic dysregulation during diabetic cardiomyopathy.Int J Cardiol. 2013 Oct 9;168(4):3160-72. doi: 10.1016/j.ijcard.2013.07.150. Epub 2013 Aug 6. Int J Cardiol. 2013. PMID: 23932046 Review.
-
Translational regulation by miR-301b upregulates AMP deaminase in diabetic hearts.J Mol Cell Cardiol. 2018 Jun;119:138-146. doi: 10.1016/j.yjmcc.2018.05.003. Epub 2018 May 4. J Mol Cell Cardiol. 2018. PMID: 29733818
-
Inhibition of AMP deaminase as therapeutic target in cardiovascular pathology.Pharmacol Rep. 2015 Aug;67(4):682-8. doi: 10.1016/j.pharep.2015.04.007. Epub 2015 Apr 29. Pharmacol Rep. 2015. PMID: 26321268 Review.
References
-
- Hancock CR, Brault JJ, Terjung RL (2006) Protecting the cellular energy state during contractions: role of AMP deaminase. J Physiol Pharmacol 57(Suppl 10):17–29 - PubMed
-
- Zabielska MA, Borkowski T, Slominska EM, Smolenski RT (2015) Inhibition of AMP deaminase as therapeutic target in cardiovascular pathology. Pharmacol Rep 67(4):682–688. https://doi.org/10.1016/j.pharep.2015.04.007 - DOI - PubMed
-
- Hong S, Zhou W, Fang B, Lu W, Loro E, Damle M, Ding G, Jager J, Zhang S, Zhang Y, Feng D, Chu Q, Dill BD, Molina H, Khurana TS, Rabinowitz JD, Lazar MA, Sun Z (2017) Dissociation of muscle insulin sensitivity from exercise endurance in mice by HDAC3 depletion. Nat Med 23(2):223–234. https://doi.org/10.1038/nm.4245 - DOI - PubMed
-
- Purzycka J (1962) AMP and adenosine aminohydrolases in rat tissues. Acta Biochim Pol 9:83–93 - PubMed
-
- Moriwaki Y, Yamamoto T, Higashino K (1999) Enzymes involved in purine metabolism–a review of histochemical localization and functional implications. Histol Histopathol 14(4):1321–1340. https://doi.org/10.14670/HH-14.1321 - DOI - PubMed
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
Medical
Miscellaneous